← 產業報告目錄

Pharmaceutical Filtration Market by Product (Membrane filter, Depth filter, Virus filter, Air Filter, Assemblies, Systems (Single-use)), Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-12-12頁數 616報告編號 BT4058

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global pharmaceutical filtration market is projected to reach USD 21.75 billion by 2030 from an estimated USD 14.35 billion in 2025, at a CAGR of 8.7% from 2025 to 2030. The expansion of the pharmaceutical filtration market has been predominantly fueled by the tightening global regulatory expectations for sterility and viral safety. However, technological limitations are expected to restrict the market. In 2024, sterile filtration was the fastest-growing segment in the pharmaceutical filtration market by type. The sterile filtration segment was the fastest-growing segment in the pharmaceutical filtration market, by type, primarily because of the growing emphasis on developing advanced therapeutic solutions and the rapid progress being made in biomedical research. As research activities expand, the need to maintain strictly sterile environments during drug development and manufacturing becomes increasingly critical. This has significantly boosted the adoption of sterile filtration technologies, which play a vital role in preventing microbial contamination, preserving product integrity, and ensuring compliance with stringent regulatory standards. These systems are essential for safeguarding the quality of biopharmaceuticals at various stages of production, particularly during cell culture preparation, upstream processing, and final formulation. Another major contributor to the segment’s growth is the rising number of approvals for biologics and biosimilars. As more complex and sensitive biological molecules enter the market, demand intensifies for reliable sterile filtration methods capable of managing high-throughput workflows without compromising sterility assurance. These biologics require robust filtration processes to remove microorganisms efficiently while maintaining structural stability and therapeutic effectiveness. Additionally, global expansion in vaccine manufacturing, driven by the need to address infectious diseases and emerging health threats, has further strengthened the demand for sterile filtration. Vaccine production heavily depends on high-performance filtration systems to eliminate contaminants and ensure safe, sterile end products. Together, these factors have firmly positioned sterile filtration as the fastest-growing segment within the pharmaceutical filtration market. The final product processing segment reported the highest share of the application segment in 2024. Within the application segment, the pharmaceutical filtration market is divided into final product processing, raw material filtration, cell separation, water purification, and air purification. In 2024, final product processing emerged as both the largest and the fastest-expanding application area in the pharmaceutical filtration industry. This dominance is primarily driven by rising regulatory expectations for product purity, sterility assurance, and contamination control throughout the final stages of drug manufacturing. As the biopharmaceutical sector continues to expand rapidly, particularly in the production of monoclonal antibodies, cell- and gene-based therapies, and vaccine platforms, the need for high-performance filtration solutions has grown significantly. Additionally, the steady increase in biologics and biosimilar production has intensified the requirement for efficient and validated filtration systems to ensure consistent quality and regulatory compliance. Collectively, these factors reinforce the strong growth trajectory of the final product processing segment within the global pharmaceutical filtration market. North America accounted for the largest market share in the global pharmaceutical filtration market in 2024. North America maintains its dominant position in the pharmaceutical filtration market due to its strong biopharmaceutical manufacturing ecosystem and rapid adoption of advanced filtration technologies. The region hosts numerous global pharma leaders, innovative biotech firms, and large CDMOs, all of which require high-performance filtration systems to support biologics, vaccines, and cell and gene therapy production. Strict regulatory standards imposed by the FDA drive continuous upgrades in membrane technologies, sterile filtration systems, and automated quality-control tools. Significant investment in R&D, coupled with a high volume of clinical trials, supports steady demand for cutting-edge filtration solutions. North America also benefits from a well-established pharmaceutical infrastructure, skilled bioprocessing talent, and extensive capacity expansions by major filtration suppliers. Government initiatives promoting biomanufacturing resilience, pandemic preparedness, and next-generation therapies further strengthen the region’s leadership, ensuring sustained technological advancement and market growth in pharmaceutical filtration. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side-70% and Demand Side-30% • By Designation: Managers-45%, CXO and Directors-30%, and Executives-25% • By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5% Key Companies Profiled in the Report Key players in the Pharmaceutical filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Solventum (US), Repligen Corporation (US), Parker Hannifin Corporation (US), Eaton Corporation plc (Ireland), Thermo Fisher Scientific Inc. (US), Donaldson Company, Inc. (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), MANN+HUMMEL (Germany), Saint-Gobain (France), STERIS plc (US), Asahi Kasei Corporation(Japan). Research Coverage This research report categorizes the Pharmaceutical Filtration Market by Product (Membrane filter, Depth filter, Virus filter, Air Filter, Assemblies, Systems [Single-use]), Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Global Forecast to 2030. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical filtration market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical filtration market. Key Benefits of Buying the Report: The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (Increasing development and commercialization of biologics and biosimilars, tightening global regulatory expectations for sterility and viral safety, growing adoption of single-use filtration systems and assemblies, rising need for sterile and high-concentration drug products, and Adoption of continuous manufacturing process), restraints (High cost of advanced filtration technologies and single-use systems, technological limitations), opportunities (Integration of smart filtration with digitalization and AI-driven process and growing focus on sustainable and eco-friendly filtration solutions) and Challenges (Stringent regulatory compliance, technical and operational challenges, lack of skilled workforce). • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the pharmaceutical filtration market • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the pharmaceutical filtration market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical filtration market.
目錄 Table of Contents
1 INTRODUCTION 54 1.1 STUDY OBJECTIVES 54 1.2 MARKET DEFINITION 54 1.3 STUDY SCOPE 55 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 55 1.3.2 INCLUSIONS & EXCLUSIONS 56 1.3.3 YEARS CONSIDERED 57 1.3.4 CURRENCY CONSIDERED 57 1.4 STAKEHOLDERS 57 1.5 SUMMARY OF CHANGES 58 2 EXECUTIVE SUMMARY 59 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 59 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 60 2.3 DISRUPTIVE TRENDS SHAPING MARKET 61 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 62 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 63 3 PREMIUM INSIGHTS 64 3.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW 64 3.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE & COUNTRY 65 3.3 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66 4 MARKET OVERVIEW 67 4.1 INTRODUCTION 67 4.2 MARKET DYNAMICS 67 4.2.1 DRIVERS 68 4.2.1.1 Rapid growth in development and commercialization of biologics and biosimilars 68 4.2.1.2 Increasing global regulatory demands for sterility and viral safety 70 4.2.1.3 Growing adoption of single-use filtration systems & assemblies 70 4.2.1.4 Rising need for sterile, high-concentration drugs 71 4.2.1.5 Adoption of continuous manufacturing process 71 4.2.2 RESTRAINTS 72 4.2.2.1 High cost of advanced filtration technologies and single-use systems 72 4.2.2.2 Technological limitations 72 4.2.3 OPPORTUNITIES 72 4.2.3.1 Smart filtration with digitalization and innovation 72 4.2.3.2 Growing focus on sustainable and eco-friendly filtration solutions 73 4.2.4 CHALLENGES 73 4.2.4.1 Stringent regulatory compliance 73 4.2.4.2 Technical and operational challenges 73 4.2.4.3 Lack of skilled workforce 74 4.3 UNMET NEEDS AND WHITE SPACES 74 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 75 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 76 5 INDUSTRY TRENDS 77 5.1 PORTER’S FIVE FORCES ANALYSIS 77 5.1.1 THREAT OF NEW ENTRANTS 78 5.1.2 THREAT OF SUBSTITUTES 78 5.1.3 BARGAINING POWER OF BUYERS 78 5.1.4 BARGAINING POWER OF SUPPLIERS 78 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 78 5.2 MACROECONOMIC OUTLOOK 79 5.2.1 INTRODUCTION 79 5.2.2 GDP TRENDS AND FORECASTS 79 5.2.3 TRENDS IN GLOBAL PHARMACEUTICAL FILTRATION MARKET 79 5.3 VALUE CHAIN ANALYSIS 80 5.4 ECOSYSTEM ANALYSIS 82 5.5 PRICING ANALYSIS 84 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024 84 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 85 5.6 TRADE ANALYSIS 86 5.6.1 IMPORT DATA FOR HS CODE 8421, 2020–2024 86 5.6.2 EXPORT DATA FOR HS CODE 8421, 2020–2024 87 5.6.3 EXPORT VOLUME FOR HS CODE 8421, 2020–2024 88 5.6.4 IMPORT VOLUME FOR HS CODE 8421, 2020–2024 89 5.7 KEY CONFERENCES & EVENTS 90 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90 5.9 INVESTMENT/FUNDING ACTIVITY 91 5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 91 5.10 CASE STUDY ANALYSIS 92 5.11 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL FILTRATION MARKET 94 5.11.1 INTRODUCTION 94 5.11.2 KEY TARIFF RATES 94 5.11.3 PRICE IMPACT ANALYSIS 95 5.11.4 IMPACT ON COUNTRY/REGION 96 5.11.4.1 US 96 5.11.4.2 Europe 96 5.11.4.3 Asia Pacific 97 5.11.5 IMPACT ON END-USE INDUSTRIES 97 5.11.5.1 Pharmaceutical & biotechnology companies 97 5.11.5.2 CROs and CDMOs/CMOs 98 5.11.5.3 Academic & research institutes 98 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 99 6.1 TECHNOLOGY ANALYSIS 99 6.1.1 KEY TECHNOLOGIES 99 6.1.1.1 Microfiltration 99 6.1.1.2 Ultrafiltration 99 6.1.1.3 Nanofiltration 100 6.1.2 COMPLEMENTARY TECHNOLOGIES 100 6.1.2.1 Electrospun microfibers 100 6.1.2.2 Photocatalytic filtration 100 6.1.3 ADJACENT TECHNOLOGIES 101 6.1.3.1 Chromatography 101 6.1.3.2 Microfluidics 101 6.2 TECHNOLOGY/PRODUCT ROADMAP 102 6.3 PATENT ANALYSIS 103 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PHARMACEUTICAL FILTRATION PATENTS, 2014–2024 103 6.4 FUTURE APPLICATIONS 104 6.5 IMPACT OF AI/GEN AI ON PHARMACEUTICAL FILTRATION MARKET 104 6.5.1 TOP USE CASES AND MARKET POTENTIAL 105 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL FILTRATION MARKET 106 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 106 6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL FILTRATION MARKET 106 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 108 7.1 REGIONAL REGULATIONS AND COMPLIANCE 108 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 7.1.2 REGULATORY FRAMEWORK 111 7.1.3 INDUSTRY STANDARDS 113 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 113 7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS 114   8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 116 8.1 DECISION-MAKING PROCESS 116 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 116 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 116 8.2.2 KEY BUYING CRITERIA, BY END USER 117 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 118 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 118 8.5 MARKET PROFITABILITY 119 9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 120 9.1 INTRODUCTION 121 9.2 CONSUMABLES 121 9.2.1 FILTERS 124 9.2.1.1 Membrane filters 127 9.2.1.1.1 Polyethersulfone (PES) 131 9.2.1.1.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth 131 9.2.1.1.2 Polyvinylidene difluoride (PVDF) 135 9.2.1.1.2.1 Nontoxic nature to increase demand for PVDF filters 135 9.2.1.1.3 Nylon 138 9.2.1.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 138 9.2.1.1.4 Polytetrafluoroethylene (PTFE) 141 9.2.1.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 141 9.2.1.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 144 9.2.1.1.5.1 MCE membranes widely used in analytical and research applications 144 9.2.1.1.6 Polycarbonate track-etched (PCTE) 148 9.2.1.1.6.1 PCTE membrane filters widely used in cell biology and analytical testing applications 148 9.2.1.1.7 Other materials 151 9.2.1.2 Depth filters 154 9.2.1.2.1 Diatomaceous Earth 157 9.2.1.2.1.1 Increasing use in biotechnology industry for cell clarification to drive market 157 9.2.1.2.2 Cellulose 160 9.2.1.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive adoption 160 9.2.1.2.3 Activated carbon 163 9.2.1.2.3.1 Widely used in pharmaceutical industry to remove range of soluble impurities from process streams containing APIs 163   9.2.1.2.4 Perlite 166 9.2.1.2.4.1 Better suited for separating coarse micro-particles from liquids with high solids loading 166 9.2.1.2.5 Other depth filter media 169 9.2.1.3 Air filters 172 9.2.1.4 Virus filters 175 9.2.1.5 Other filters 178 9.2.2 OTHER CONSUMABLES 182 9.2.2.1 FILTRATION ASSEMBLIES 185 9.2.2.1.1 Microfiltration assemblies 188 9.2.2.1.1.1 Growing demand for high-quality products to support segment growth 188 9.2.2.1.2 Ultrafiltration assemblies 192 9.2.2.1.2.1 Stringent regulatory requirements to support segment growth 192 9.2.2.1.3 Nanofiltration assemblies 195 9.2.2.1.3.1 Increasing demand for high-purity biopharmaceuticals to propel market 195 9.2.2.1.4 Other filtration assemblies 199 9.2.2.2 FILTER HOLDERS 202 9.2.2.2.1 Filter holders provide structural support to membrane filters 202 9.2.2.3 FILTRATION ACCESSORIES 205 9.2.2.3.1 Increasing adoption of pharmaceutical filtration products to support growth 205 9.3 SYSTEMS 208 9.3.1 SINGLE-USE SYSTEMS 211 9.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 211 9.3.2 REUSABLE SYSTEMS 215 9.3.2.1 Widely used for large-scale manufacturing to drive adoption 215 10 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 218 10.1 INTRODUCTION 219 10.2 MICROFILTRATION 219 10.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL GROWTH 219 10.3 ULTRAFILTRATION 222 10.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH 222 10.4 NANOFILTRATION 224 10.4.1 RISING DEMAND IN BIOTECHNOLOGY INDUSTRY TO SUPPORT MARKET GROWTH 224 10.5 OTHER TECHNIQUES 227   11 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 231 11.1 INTRODUCTION 232 11.2 STERILE FILTRATION 232 11.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 232 11.3 NON-STERILE FILTRATION 235 11.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROPEL MARKET 235 12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 238 12.1 INTRODUCTION 239 12.2 FINAL PRODUCT PROCESSING 239 12.2.1 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION 243 12.2.1.1 Continuous requirement for API filtration to drive market 243 12.2.2 PROTEIN PURIFICATION 247 12.2.2.1 Recent advancements in protein therapeutic drugs to propel growth 247 12.2.3 VACCINE AND ANTIBODY PROCESSING 250 12.2.3.1 Development of vaccines for viral diseases to drive growth 250 12.2.4 FORMULATION AND FILLING SOLUTIONS 254 12.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 254 12.2.5 VIRAL CLEARANCE 257 12.2.5.1 Growing development of therapeutic monoclonal antibodies to drive market 257 12.3 RAW MATERIAL FILTRATION 260 12.3.1 MEDIA AND BUFFER FILTRATION 263 12.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 263 12.3.2 PREFILTRATION 267 12.3.2.1 Membrane fouling issues to drive growth 267 12.3.3 BIOBURDEN TESTING 270 12.3.3.1 Strict quality control of biopharmaceuticals to drive growth 270 12.4 CELL SEPARATION 273 12.4.1 GROWTH IN PERSONALIZED MEDICINE AND CELL THERAPIES TO PROPEL MARKET 273 12.5 WATER PURIFICATION 276 12.5.1 REQUIREMENT IN RESEARCH AND FORMULATION TO DRIVE MARKET 276 12.6 AIR PURIFICATION 279 12.6.1 INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH 279 13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION 282 13.1 INTRODUCTION 283 13.2 MANUFACTURING-SCALE 283 13.2.1 GROWTH IN BIOLOGICS AND BIOSIMILARS MANUFACTURING TO DRIVE MARKET 283   13.3 PILOT-SCALE 288 13.3.1 INCREASED OUTSOURCING OF PILOT-SCALE BIOPROCESS DEVELOPMENT TO DRIVE MARKET 288 13.4 R&D-SCALE 291 13.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 291 14 PHARMACEUTICAL FILTRATION MARKET, BY END USER 295 14.1 INTRODUCTION 296 14.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 296 14.2.1 GROWING BIOLOGICS PRODUCTION TO PROPEL DEMAND 296 14.3 CROS & CMOS 300 14.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO DRIVE MARKET 300 14.4 ACADEMIC & RESEARCH INSTITUTES 303 14.4.1 RISING DEMAND FOR LABORATORY FILTRATION ACROSS CROS AND RESEARCH INSTITUTES TO PROPEL MARKET 303 15 PHARMACEUTICAL FILTRATION MARKET, BY REGION 307 15.1 INTRODUCTION 308 15.2 NORTH AMERICA 308 15.2.1 NORTH AMERICA: MACROECONOMIC ANALYSIS 309 15.2.2 US 317 15.2.2.1 US to dominate North America market during forecast period 317 15.2.3 CANADA 323 15.2.3.1 Growing government support for expanding biologics manufacturing facilities to support market growth 323 15.3 EUROPE 328 15.3.1 EUROPE: MACROECONOMIC ANALYSIS 328 15.3.2 GERMANY 336 15.3.2.1 Growing pharmaceutical R&D and manufacturing to drive market 336 15.3.3 UK 342 15.3.3.1 Increased awareness of drug quality led to greater use of filtration products in drug discovery laboratories 342 15.3.4 FRANCE 348 15.3.4.1 Government investment in pharmaceutical industry to drive growth 348 15.3.5 ITALY 354 15.3.5.1 Investment in biotechnology R&D to boost market growth 354 15.3.6 SPAIN 360 15.3.6.1 Expansion of biomanufacturing facilities to support market growth 360 15.3.7 SWITZERLAND 366 15.3.7.1 Presence of key pharmaceutical and biopharmaceutical companies to support market growth 366 15.3.8 REST OF EUROPE 372   15.4 ASIA PACIFIC 378 15.4.1 ASIA PACIFIC: MACROECONOMIC ANALYSIS 379 15.4.2 CHINA 386 15.4.2.1 China to dominate Asia Pacific market during forecast period 386 15.4.3 JAPAN 392 15.4.3.1 Stringent regulatory guidelines to create need for advanced filtration products 392 15.4.4 INDIA 398 15.4.4.1 Favorable scenario for foreign direct investment to favor market growth 398 15.4.5 SOUTH KOREA 404 15.4.5.1 Increased export of drugs to support market growth 404 15.4.6 AUSTRALIA 410 15.4.6.1 Increasing demand for innovative filtration solutions to propel market 410 15.4.7 REST OF ASIA PACIFIC 416 15.5 LATIN AMERICA 422 15.5.1 LATIN AMERICA: MACROECONOMIC ANALYSIS 422 15.5.2 BRAZIL 429 15.5.2.1 Increased government investments in pharmaceutical R&D to drive market 429 15.5.3 MEXICO 435 15.5.3.1 Rising demand for chronic disease treatment to support market growth 435 15.5.4 REST OF LATIN AMERICA 441 15.6 MIDDLE EAST 447 15.6.1 MIDDLE EAST: MACROECONOMIC ANALYSIS 447 15.6.2 GCC COUNTRIES 454 15.6.2.1 Saudi Arabia 460 15.6.2.1.1 Growing healthcare expenditure to boost market growth 460 15.6.2.2 UAE 466 15.6.2.2.1 Adoption of more efficient and precise filtration processes to aid market growth 466 15.6.2.3 Rest of GCC Countries 472 15.6.3 REST OF MIDDLE EAST 478 15.7 AFRICA 483 15.7.1 AFRICA: MACROECONOMIC ANALYSIS 483 16 COMPETITIVE LANDSCAPE 490 16.1 INTRODUCTION 490 16.2 STRATEGIES ADOPTED BY KEY PLAYERS 490 16.3 REVENUE SHARE ANALYSIS 492 16.4 MARKET SHARE ANALYSIS 492 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 494 16.5.1 STARS 495 16.5.2 EMERGING LEADERS 495 16.5.3 PERVASIVE PLAYERS 495 16.5.4 PARTICIPANTS 495 16.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2024 497 16.5.5.1 Company footprint 497 16.5.5.2 Product footprint 498 16.5.5.3 Technique footprint 499 16.5.5.4 Application footprint 500 16.5.5.5 Regional footprint 501 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 502 16.6.1 PROGRESSIVE COMPANIES 502 16.6.2 RESPONSIVE COMPANIES 502 16.6.3 DYNAMIC COMPANIES 502 16.6.4 STARTING BLOCKS 503 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 504 16.6.5.1 Detailed list of key startups/SMEs, 2024 504 16.6.5.2 Competitive benchmarking of key startups/SMEs, 2024 505 16.7 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL FILTRATION VENDORS 506 16.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 507 16.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 507 16.9 COMPETITIVE SCENARIO 508 16.9.1 PRODUCT LAUNCHES 508 16.9.2 DEALS 509 16.9.3 EXPANSIONS 510 17 COMPANY PROFILES 511 17.1 KEY PLAYERS 511 17.1.1 MERCK KGAA 511 17.1.1.1 Business overview 511 17.1.1.2 Products offered 512 17.1.1.3 Recent developments 516 17.1.1.3.1 Expansions 516 17.1.1.4 MnM view 517 17.1.1.4.1 Key strengths 517 17.1.1.4.2 Strategic choices 517 17.1.1.4.3 Weaknesses and competitive threats 517 17.1.2 DANAHER CORPORATION 518 17.1.2.1 Business overview 518 17.1.2.2 Products offered 519 17.1.2.3 Recent developments 525 17.1.2.3.1 Product launches 525 17.1.2.3.2 Deals 525 17.1.2.3.3 Expansions 525 17.1.2.4 MnM view 526 17.1.2.4.1 Key strengths 526 17.1.2.4.2 Strategic choices 526 17.1.2.4.3 Weaknesses and competitive threats 526 17.1.3 SARTORIUS AG 527 17.1.3.1 Business overview 527 17.1.3.2 Products offered 528 17.1.3.3 Recent developments 531 17.1.3.3.1 Product launches 531 17.1.3.3.2 Deals 531 17.1.3.3.3 Expansions 531 17.1.3.4 MnM view 532 17.1.3.4.1 Key strengths 532 17.1.3.4.2 Strategic choices 532 17.1.3.4.3 Weaknesses and competitive threats 532 17.1.4 SOLVENTUM 533 17.1.4.1 Business overview 533 17.1.4.2 Products offered 534 17.1.4.3 Recent developments 536 17.1.4.3.1 Product launches 536 17.1.4.3.2 Deals 537 17.1.4.3.3 Other developments 537 17.1.4.4 MnM view 537 17.1.4.4.1 Key strengths 537 17.1.4.4.2 Strategic choices 538 17.1.4.4.3 Weaknesses and competitive threats 538 17.1.5 PARKER HANNIFIN CORPORATION 539 17.1.5.1 Business overview 539 17.1.5.2 Products offered 540 17.1.5.3 MnM view 542 17.1.5.3.1 Key strengths 542 17.1.5.3.2 Strategic choices 542 17.1.5.3.3 Weaknesses and competitive threats 542 17.1.6 REPLIGEN CORPORATION 543 17.1.6.1 Business overview 543 17.1.6.2 Products offered 544 17.1.6.3 Recent developments 546 17.1.6.3.1 Product launches 546 17.1.6.3.2 Deals 546   17.1.7 EATON CORPORATION PLC 547 17.1.7.1 Business overview 547 17.1.7.2 Products offered 548 17.1.7.3 Recent developments 550 17.1.7.3.1 Product launches 550 17.1.8 THERMO FISHER SCIENTIFIC, INC. 551 17.1.8.1 Business overview 551 17.1.8.2 Products offered 552 17.1.8.3 Recent developments 555 17.1.8.3.1 Deals 555 17.1.8.3.2 Expansions 555 17.1.9 DONALDSON COMPANY, INC. 557 17.1.9.1 Business overview 557 17.1.9.2 Products offered 558 17.1.9.3 Recent developments 559 17.1.9.3.1 Deals 559 17.1.9.3.2 Expansions 560 17.1.10 PORVAIR PLC 561 17.1.10.1 Business overview 561 17.1.10.2 Products offered 562 17.1.10.3 Recent developments 564 17.1.10.3.1 Product launches 564 17.1.11 ALFA LAVAL CORPORATE AB 565 17.1.11.1 Business overview 565 17.1.11.2 Products offered 566 17.1.11.3 Recent developments 567 17.1.11.3.1 Product launches 567 17.1.12 CORNING INCORPORATED 568 17.1.12.1 Business overview 568 17.1.12.2 Products offered 569 17.1.13 MANN+HUMMEL 572 17.1.13.1 Business overview 572 17.1.13.2 Products offered 573 17.1.13.3 Recent developments 574 17.1.13.3.1 Deals 574 17.1.14 SAINT-GOBAIN 575 17.1.14.1 Business overview 575 17.1.14.2 Products offered 576 17.1.14.3 Recent developments 577 17.1.14.3.1 Product launches 577 17.1.14.3.2 Expansions 577 17.1.15 STERIS PLC 578 17.1.15.1 Business overview 578 17.1.15.2 Products offered 579 17.1.16 ASAHI KASEI CORPORATION 580 17.1.16.1 Business overview 580 17.1.16.2 Products offered 581 17.1.16.3 Recent developments 581 17.1.16.3.1 Product launches 581 17.1.16.3.2 Deals 582 17.1.16.3.3 Expansions 582 17.2 OTHER PLAYERS 583 17.2.1 MEISSNER FILTRATION PRODUCTS, INC. 583 17.2.2 AMAZON FILTERS LTD. 584 17.2.3 GRAVER TECHNOLOGIES, LLC 586 17.2.4 MMS AG 588 17.2.5 ERTELALSOP 589 17.2.6 KASAG SWISS AG 590 17.2.7 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG 591 17.2.8 ANTYLIA SCIENTIFIC 592 17.2.9 FILTROX AG 593 17.2.10 MEMBRANE SOLUTIONS 594 18 RESEARCH METHODOLOGY 595 18.1 RESEARCH DATA 595 18.1.1 SECONDARY DATA 596 18.1.2 PRIMARY DATA 596 18.2 MARKET ESTIMATION METHODOLOGY 598 18.2.1 MARKET SIZE ESTIMATION 598 18.2.2 INSIGHTS OF PRIMARY EXPERTS 600 18.2.3 TOP-DOWN APPROACH 601 18.3 MARKET GROWTH RATE PROJECTIONS 602 18.4 MARKET BREAKDOWN AND DATA TRIANGULATION 603 18.5 RESEARCH ASSUMPTIONS 604 18.6 RESEARCH LIMITATIONS 605 18.7 RISK ANALYSIS 605 19 APPENDIX 606 19.1 DISCUSSION GUIDE 606 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 611 19.3 CUSTOMIZATION OPTIONS 613 19.4 RELATED REPORTS 614 19.5 AUTHOR DETAILS 615
圖表清單 List of Tables & Figures
TABLE 1 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS 68 TABLE 2 LIST OF KEY BIOSIMILARS APPROVED, 2023–2025 69 TABLE 3 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 77 TABLE 4 PHARMACEUTICAL FILTRATION MARKET: ROLE IN ECOSYSTEM 82 TABLE 5 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024 84 TABLE 6 AVERAGE SELLING PRICE, BY REGION, 2022–2024 85 TABLE 7 IMPORT DATA FOR HS CODE 8421, BY COUNTRY, 2020–2024 (USD THOUSAND) 86 TABLE 8 EXPORT DATA FOR HS CODE 8421, BY COUNTRY, 2020–2024 (USD THOUSAND) 87 TABLE 9 EXPORT VOLUME FOR HS CODE 8421, BY COUNTRY, 2020–2024 (TON) 88 TABLE 10 IMPORT VOLUME FOR HS CODE 8421, BY COUNTRY, 2020–2024 (TON) 89 TABLE 11 PHARMACEUTICAL FILTRATION MARKET: KEY CONFERENCES & EVENTS, 2025–2027 90 TABLE 12 ADVANCED VIRAL FILTRATION ENABLING SAFE MAB PRODUCTION SCALE-UP 92 TABLE 13 RAPID SCALE-UP OF VIRAL VECTOR FILTRATION FOR COVID-19 VACCINE 93 TABLE 14 HIGH-THROUGHPUT VIRAL FILTRATION OPTIMIZATION 93 TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 94 TABLE 16 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 95 TABLE 17 INDICATIVE LIST OF PATENTS IN PHARMACEUTICAL FILTRATION MARKET, 2025 104 TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL FILTRATION MARKET 106 TABLE 19 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL FILTRATION MARKET 107 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 24 COUNTRY-WISE REGULATORY SCENARIO FOR PHARMACEUTICAL FILTER MANUFACTURERS 111 TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCTS (%) 116 TABLE 26 KEY BUYING CRITERIA, BY END USER 117 TABLE 27 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 121 TABLE 28 PHARMACEUTICAL CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 29 NORTH AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 30 EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 31 ASIA PACIFIC: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 32 LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 33 MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 34 GCC COUNTRIES: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 35 PHARMACEUTICAL FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 36 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 37 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 38 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 39 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 40 MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 41 GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 42 PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 43 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 44 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 45 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 46 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 47 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 48 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 49 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 50 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 131 TABLE 51 POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 52 NORTH AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 53 EUROPE: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 54 ASIA PACIFIC: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 55 LATIN AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 56 MIDDLE EAST: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 57 GCC COUNTRIES: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 58 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 59 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 60 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 61 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 62 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 63 MIDDLE EAST: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 64 GCC COUNTRIES: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 65 NYLON MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 66 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 67 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 68 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 69 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 70 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 71 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 72 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 73 NORTH AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 74 EUROPE: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 75 ASIA PACIFIC: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 76 LATIN AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 77 MIDDLE EAST: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 78 GCC COUNTRIES: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 79 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 80 NORTH AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 81 EUROPE: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 82 ASIA PACIFIC: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 83 LATIN AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 84 MIDDLE EAST: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 85 GCC COUNTRIES: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 86 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 87 NORTH AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 88 EUROPE: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 89 ASIA PACIFIC: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 90 LATIN AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 91 MIDDLE EAST: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 92 GCC COUNTRIES: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 93 OTHER MEMBRANE FILTER MATERIALS MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 94 NORTH AMERICA: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 95 EUROPE: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 96 ASIA PACIFIC: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 97 LATIN AMERICA: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 98 MIDDLE EAST: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 99 GCC COUNTRIES: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 100 DEPTH FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 101 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 102 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 103 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 104 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 105 MIDDLE EAST: DEPTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 106 GCC COUNTRIES: DEPTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 107 DEPTH FILTERS MARKET, BY MEDIA, 2023–2030 (USD MILLION) 157 TABLE 108 DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 109 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 110 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 111 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 112 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 113 MIDDLE EAST: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 114 GCC COUNTRIES: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 115 CELLULOSE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 116 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 117 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 118 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 119 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 120 MIDDLE EAST: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 121 GCC COUNTRIES: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 122 ACTIVATED CARBON FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 163 TABLE 123 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 124 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 125 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 126 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 127 MIDDLE EAST: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 128 GCC COUNTRIES: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 129 PERLITE FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 130 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 131 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 132 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 133 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 134 MIDDLE EAST: PERLITE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 135 GCC COUNTRIES: PERLITE FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 136 OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 137 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 138 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 139 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 140 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 141 MIDDLE EAST: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 142 GCC COUNTRIES: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 143 AIR FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 144 NORTH AMERICA: AIR FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 145 EUROPE: AIR FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 146 ASIA PACIFIC: AIR FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 147 LATIN AMERICA: AIR FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 148 MIDDLE EAST: AIR FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 149 GCC COUNTRIES: AIR FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 150 VIRUS FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 151 NORTH AMERICA: VIRUS FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 152 EUROPE: VIRUS FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 153 ASIA PACIFIC: VIRUS FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 154 LATIN AMERICA: VIRUS FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 155 MIDDLE EAST: VIRUS FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 156 GCC COUNTRIES: VIRUS FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 157 OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 158 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 159 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 160 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 161 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 162 MIDDLE EAST: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 163 GCC COUNTRIES: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 164 OTHER CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 165 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 166 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 167 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 168 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 169 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 170 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 171 OTHER CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 172 FILTRATION ASSEMBLIES MARKET, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 173 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 174 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 175 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 176 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 177 MIDDLE EAST: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 178 GCC COUNTRIES: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 179 FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 180 MICROFILTRATION ASSEMBLIES MARKET, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 181 NORTH AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 182 EUROPE: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 183 ASIA PACIFIC: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 184 LATIN AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 185 MIDDLE EAST: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 186 GCC COUNTRIES: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 187 ULTRAFILTRATION ASSEMBLIES MARKET, BY REGION, 2023–2030 (USD MILLION) 192 TABLE 188 NORTH AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 189 EUROPE: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 190 ASIA PACIFIC: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 191 LATIN AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 192 MIDDLE EAST: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 193 GCC COUNTRIES: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 194 NANOFILTRATION ASSEMBLIES MARKET, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 195 NORTH AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 196 EUROPE: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 197 ASIA PACIFIC: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 198 LATIN AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 199 MIDDLE EAST: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 200 GCC COUNTRIES: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 201 OTHER FILTRATION ASSEMBLIES MARKET, BY REGION, 2023–2030 (USD MILLION) 199 TABLE 202 NORTH AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 203 EUROPE: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 204 ASIA PACIFIC: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 205 LATIN AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 206 MIDDLE EAST: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 207 GCC COUNTRIES: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 208 FILTER HOLDERS MARKET, BY REGION, 2023–2030 (USD MILLION) 202 TABLE 209 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 210 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 211 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 212 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 213 MIDDLE EAST: FILTER HOLDERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 214 GCC COUNTRIES: FILTER HOLDERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 215 FILTRATION ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 216 NORTH AMERICA: FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 217 EUROPE: FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 218 ASIA PACIFIC: FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 219 LATIN AMERICA: FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 220 MIDDLE EAST: FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 221 GCC COUNTRIES: FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 222 FILTRATION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 208 TABLE 223 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 208 TABLE 224 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 225 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 226 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 227 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 228 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 229 FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 230 SINGLE-USE SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 212 TABLE 231 NORTH AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 232 EUROPE: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 233 ASIA PACIFIC: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 234 LATIN AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 235 MIDDLE EAST: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 236 GCC COUNTRIES: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 237 REUSABLE SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 215 TABLE 238 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 239 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 240 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 241 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 242 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 243 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 244 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 219 TABLE 245 MICROFILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 220 TABLE 246 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 247 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220 TABLE 248 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 249 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 250 MIDDLE EAST: MICROFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 251 GCC COUNTRIES: MICROFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 252 ULTRAFILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 222 TABLE 253 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 254 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 255 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 256 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 257 MIDDLE EAST: ULTRAFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 258 GCC COUNTRIES: ULTRAFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224 TABLE 259 NANOFILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 225 TABLE 260 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 261 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 262 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 263 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 264 MIDDLE EAST: NANOFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 265 GCC COUNTRIES: NANOFILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 266 OTHER FILTRATION TECHNIQUES MARKET, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 267 NORTH AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 268 EUROPE: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 269 ASIA PACIFIC: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 270 LATIN AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 271 MIDDLE EAST: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 272 GCC COUNTRIES: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 273 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 274 STERILE FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 233 TABLE 275 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 276 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 277 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 278 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 279 MIDDLE EAST: STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 280 GCC COUNTRIES: STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 235 TABLE 281 NON-STERILE FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 235 TABLE 282 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 283 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 284 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 285 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 286 MIDDLE EAST: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 287 GCC COUNTRIES: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 288 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239 TABLE 289 PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 290 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 291 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 292 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 293 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 294 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 295 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 296 PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 297 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 244 TABLE 298 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 244 TABLE 299 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 300 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 301 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 302 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 303 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 304 PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2023–2030 (USD MILLION) 247 TABLE 305 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 306 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 307 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 308 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 309 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 310 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 311 PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2023–2030 (USD MILLION) 251 TABLE 312 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 313 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 314 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 315 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 316 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 317 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 318 PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 254 TABLE 319 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 320 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 321 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 322 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 323 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 324 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 325 PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2023–2030 (USD MILLION) 257 TABLE 326 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 327 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023–2030 (USD MILLION) 258 TABLE 328 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 329 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 330 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 331 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023–2030 (USD MILLION) 260 TABLE 332 PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2023–2030 (USD MILLION) 260 TABLE 333 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 334 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 335 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 262 TABLE 336 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 262 TABLE 337 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 262 TABLE 338 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 263 TABLE 339 PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 340 PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY REGION, 2023–2030 (USD MILLION) 264 TABLE 341 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 264 TABLE 342 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 265 TABLE 343 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 265 TABLE 344 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 266 TABLE 345 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 266 TABLE 346 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA AND BUFFER FILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 266 TABLE 347 PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION, 2023–2030 (USD MILLION) 267 TABLE 348 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 349 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 350 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 351 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 352 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 353 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 354 PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2023–2030 (USD MILLION) 270 TABLE 355 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 270 TABLE 356 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 357 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 358 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 359 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 360 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 361 PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2023–2030 (USD MILLION) 273 TABLE 362 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2023–2030 (USD MILLION) 273 TABLE 363 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2023–2030 (USD MILLION) 274 TABLE 364 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2023–2030 (USD MILLION) 274 TABLE 365 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 366 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 367 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 368 PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2023–2030 (USD MILLION) 276 TABLE 369 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 276 TABLE 370 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 277 TABLE 371 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 277 TABLE 372 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 373 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 374 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 375 PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2023–2030 (USD MILLION) 279 TABLE 376 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 279 TABLE 377 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 378 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 379 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 380 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 381 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2023–2030 (USD MILLION) 281 TABLE 382 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 283 TABLE 383 LIST OF FDA-APPROVED BIOSIMILAR PRODUCTS, 2022–2024 284 TABLE 384 MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 285 TABLE 385 NORTH AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 285 TABLE 386 EUROPE: MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 387 ASIA PACIFIC: MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 286 TABLE 388 LATIN AMERICA: MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 287 TABLE 389 MIDDLE EAST: MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 287 TABLE 390 GCC COUNTRIES: MANUFACTURING-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 287 TABLE 391 PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 288 TABLE 392 NORTH AMERICA: PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 393 EUROPE: PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 289 TABLE 394 ASIA PACIFIC: PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 290 TABLE 395 LATIN AMERICA: PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 290 TABLE 396 MIDDLE EAST: PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 290 TABLE 397 GCC COUNTRIES: PILOT-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 291 TABLE 398 R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 292 TABLE 399 NORTH AMERICA: R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 292 TABLE 400 EUROPE: R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 293 TABLE 401 ASIA PACIFIC: R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 293 TABLE 402 LATIN AMERICA: R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 294 TABLE 403 MIDDLE EAST: R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 294 TABLE 404 GCC COUNTRIES: R&D-SCALE PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 294 TABLE 405 PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 296 TABLE 406 PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 297 TABLE 407 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 297 TABLE 408 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 298 TABLE 409 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 298 TABLE 410 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 299 TABLE 411 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 299 TABLE 412 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 299 TABLE 413 PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY REGION, 2023–2030 (USD MILLION) 300 TABLE 414 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY COUNTRY, 2023–2030 (USD MILLION) 301 TABLE 415 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY COUNTRY, 2023–2030 (USD MILLION) 301 TABLE 416 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY COUNTRY, 2023–2030 (USD MILLION) 302 TABLE 417 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY COUNTRY, 2023–2030 (USD MILLION) 302 TABLE 418 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY COUNTRY, 2023–2030 (USD MILLION) 302 TABLE 419 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR CROS & CMOS, BY COUNTRY, 2023–2030 (USD MILLION) 303 TABLE 420 PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 304 TABLE 421 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 304 TABLE 422 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 305 TABLE 423 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 305 TABLE 424 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 306 TABLE 425 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 306 TABLE 426 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 306 TABLE 427 PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2023–2030 (USD MILLION) 308 TABLE 428 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN NORTH AMERICA 310 TABLE 429 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 311 TABLE 430 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 311 TABLE 431 NORTH AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 432 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 433 NORTH AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 312 TABLE 434 NORTH AMERICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 313 TABLE 435 NORTH AMERICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 436 NORTH AMERICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 437 NORTH AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 438 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 314 TABLE 439 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 440 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 315 TABLE 441 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 442 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 443 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 316 TABLE 444 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 316 TABLE 445 US: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 318 TABLE 446 US: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 447 US: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 448 US: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 319 TABLE 449 US: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 319 TABLE 450 US: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 451 US: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 452 US: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 453 US: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 320 TABLE 454 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 455 US: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 321 TABLE 456 US: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 457 US: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 322 TABLE 458 US: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 322 TABLE 459 US: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 322 TABLE 460 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 323 TABLE 461 CANADA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 462 CANADA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 463 CANADA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 324 TABLE 464 CANADA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 324 TABLE 465 CANADA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 466 CANADA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 467 CANADA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 468 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 326 TABLE 469 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 470 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 326 TABLE 471 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 472 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 473 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 327 TABLE 474 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 328 TABLE 475 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN EUROPE 329 TABLE 476 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 330 TABLE 477 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 330 TABLE 478 EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 479 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 480 EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 331 TABLE 481 EUROPE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 332 TABLE 482 EUROPE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 483 EUROPE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 484 EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 485 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 333 TABLE 486 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 487 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 334 TABLE 488 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 334 TABLE 489 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 490 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 335 TABLE 491 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 335 TABLE 492 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 336 TABLE 493 GERMANY: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 494 GERMANY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 495 GERMANY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 337 TABLE 496 GERMANY: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 338 TABLE 497 GERMANY: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 498 GERMANY: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 499 GERMANY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 500 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 339 TABLE 501 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 502 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 340 TABLE 503 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 504 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 505 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 341 TABLE 506 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 341 TABLE 507 UK: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 342 TABLE 508 UK: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 509 UK: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 510 UK: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 343 TABLE 511 UK: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 344 TABLE 512 UK: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 513 UK: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 514 UK: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 515 UK: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 345 TABLE 516 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 517 UK: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 346 TABLE 518 UK: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 519 UK: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 520 UK: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 347 TABLE 521 UK: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 347 TABLE 522 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 348 TABLE 523 FRANCE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 524 FRANCE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 525 FRANCE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 349 TABLE 526 FRANCE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 350 TABLE 527 FRANCE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 528 FRANCE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 529 FRANCE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 530 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 351 TABLE 531 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 532 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 352 TABLE 533 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 534 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 535 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 353 TABLE 536 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 353 TABLE 537 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 354 TABLE 538 ITALY: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 354 TABLE 539 ITALY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 540 ITALY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 355 TABLE 541 ITALY: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 356 TABLE 542 ITALY: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 543 ITALY: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 544 ITALY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 545 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 357 TABLE 546 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 547 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 358 TABLE 548 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 549 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 550 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 359 TABLE 551 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 359 TABLE 552 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 360 TABLE 553 SPAIN: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 554 SPAIN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 361 TABLE 555 SPAIN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 361 TABLE 556 SPAIN: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 362 TABLE 557 SPAIN: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 558 SPAIN: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 559 SPAIN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 560 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 363 TABLE 561 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 562 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 364 TABLE 563 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 564 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 565 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 365 TABLE 566 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 365 TABLE 567 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 366 TABLE 568 SWITZERLAND: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 569 SWITZERLAND: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 570 SWITZERLAND: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 367 TABLE 571 SWITZERLAND: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 368 TABLE 572 SWITZERLAND: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 573 SWITZERLAND: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 574 SWITZERLAND: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 575 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 369 TABLE 576 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 577 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 370 TABLE 578 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 579 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 580 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 371 TABLE 581 SWITZERLAND: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 371 TABLE 582 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 372 TABLE 583 REST OF EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 584 REST OF EUROPE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 585 REST OF EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 373 TABLE 586 REST OF EUROPE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 374 TABLE 587 REST OF EUROPE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 588 REST OF EUROPE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 589 REST OF EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 590 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 375 TABLE 591 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 592 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 376 TABLE 593 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 376 TABLE 594 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 595 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 377 TABLE 596 REST OF EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 377 TABLE 597 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN ASIA PACIFIC 380 TABLE 598 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 380 TABLE 599 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 381 TABLE 600 ASIA PACIFIC: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 601 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 381 TABLE 602 ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 382 TABLE 603 ASIA PACIFIC: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 382 TABLE 604 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 605 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 606 ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 607 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 383 TABLE 608 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 609 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 384 TABLE 610 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 611 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 385 TABLE 612 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 385 TABLE 613 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 385 TABLE 614 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 386 TABLE 615 CHINA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 616 CHINA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 387 TABLE 617 CHINA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 387 TABLE 618 CHINA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 388 TABLE 619 CHINA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 620 CHINA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 621 CHINA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 622 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 389 TABLE 623 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 624 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 390 TABLE 625 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 390 TABLE 626 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 391 TABLE 627 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 391 TABLE 628 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 391 TABLE 629 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 392 TABLE 630 JAPAN: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 393 TABLE 631 JAPAN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 393 TABLE 632 JAPAN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 393 TABLE 633 JAPAN: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 394 TABLE 634 JAPAN: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 635 JAPAN: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 636 JAPAN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 637 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 395 TABLE 638 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 395 TABLE 639 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 396 TABLE 640 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 641 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 397 TABLE 642 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 397 TABLE 643 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 397 TABLE 644 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 398 TABLE 645 INDIA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 646 INDIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 647 INDIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 399 TABLE 648 INDIA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 400 TABLE 649 INDIA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 650 INDIA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 400 TABLE 651 INDIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 652 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 401 TABLE 653 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 654 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 402 TABLE 655 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 656 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 657 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 403 TABLE 658 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 403 TABLE 659 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 404 TABLE 660 SOUTH KOREA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 404 TABLE 661 SOUTH KOREA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 662 SOUTH KOREA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 405 TABLE 663 SOUTH KOREA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 406 TABLE 664 SOUTH KOREA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 665 SOUTH KOREA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 406 TABLE 666 SOUTH KOREA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 667 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 407 TABLE 668 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 669 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 408 TABLE 670 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 408 TABLE 671 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 409 TABLE 672 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 409 TABLE 673 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 409 TABLE 674 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 410 TABLE 675 AUSTRALIA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 676 AUSTRALIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 411 TABLE 677 AUSTRALIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 411 TABLE 678 AUSTRALIA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 412 TABLE 679 AUSTRALIA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 680 AUSTRALIA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 681 AUSTRALIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 682 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 413 TABLE 683 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 684 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 414 TABLE 685 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 414 TABLE 686 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 415 TABLE 687 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 415 TABLE 688 AUSTRALIA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 415 TABLE 689 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 416 TABLE 690 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 691 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 692 REST OF ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 417 TABLE 693 REST OF ASIA PACIFIC: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 418 TABLE 694 REST OF ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 695 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 418 TABLE 696 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 697 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 419 TABLE 698 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 419 TABLE 699 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 420 TABLE 700 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 701 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 421 TABLE 702 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 421 TABLE 703 REST OF ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 421 TABLE 704 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 423 TABLE 705 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 423 TABLE 706 LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 423 TABLE 707 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 424 TABLE 708 LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 424 TABLE 709 LATIN AMERICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 425 TABLE 710 LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 711 LATIN AMERICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 425 TABLE 712 LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 426 TABLE 713 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 426 TABLE 714 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 426 TABLE 715 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 427 TABLE 716 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 427 TABLE 717 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 428 TABLE 718 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 428 TABLE 719 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 428 TABLE 720 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 429 TABLE 721 BRAZIL: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 429 TABLE 722 BRAZIL: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 430 TABLE 723 BRAZIL: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 430 TABLE 724 BRAZIL: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 431 TABLE 725 BRAZIL : OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 431 TABLE 726 BRAZIL: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 431 TABLE 727 BRAZIL: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 728 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 432 TABLE 729 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 432 TABLE 730 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 433 TABLE 731 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 433 TABLE 732 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 434 TABLE 733 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 434 TABLE 734 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 434 TABLE 735 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 435 TABLE 736 MEXICO: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 435 TABLE 737 MEXICO: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 436 TABLE 738 MEXICO: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 436 TABLE 739 MEXICO: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 437 TABLE 740 MEXICO: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 741 MEXICO: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 437 TABLE 742 MEXICO: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 438 TABLE 743 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 438 TABLE 744 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 438 TABLE 745 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 439 TABLE 746 MEXICO: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 439 TABLE 747 MEXICO: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 440 TABLE 748 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 440 TABLE 749 MEXICO: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 440 TABLE 750 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 441 TABLE 751 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 441 TABLE 752 REST OF LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 442 TABLE 753 REST OF LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 442 TABLE 754 REST OF LATIN AMERICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 443 TABLE 755 REST OF LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 443 TABLE 756 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 443 TABLE 757 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 758 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 444 TABLE 759 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 444 TABLE 760 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 445 TABLE 761 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 445 TABLE 762 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 446 TABLE 763 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 446 TABLE 764 REST OF LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 446 TABLE 765 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN MIDDLE EAST 448 TABLE 766 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2023–2030 (SD MILLION) 448 TABLE 767 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 448 TABLE 768 MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 769 MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 449 TABLE 770 MIDDLE EAST: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 449 TABLE 771 MIDDLE EAST: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 450 TABLE 772 MIDDLE EAST: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 450 TABLE 773 MIDDLE EAST: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 450 TABLE 774 MIDDLE EAST: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 775 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 451 TABLE 776 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 451 TABLE 777 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 452 TABLE 778 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 452 TABLE 779 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 453 TABLE 780 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 453 TABLE 781 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 453 TABLE 782 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 454 TABLE 783 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 454 TABLE 784 GCC COUNTRIES: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 785 GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 455 TABLE 786 GCC COUNTRIES: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 455 TABLE 787 GCC COUNTRIES: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 456 TABLE 788 GCC COUNTRIES: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 789 GCC COUNTRIES: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 456 TABLE 790 GCC COUNTRIES: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 791 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 457 TABLE 792 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 457 TABLE 793 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 458 TABLE 794 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 458 TABLE 795 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 459 TABLE 796 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 459 TABLE 797 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 459 TABLE 798 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 460 TABLE 799 SAUDI ARABIA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 460 TABLE 800 SAUDI ARABIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 461 TABLE 801 SAUDI ARABIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 461 TABLE 802 SAUDI ARABIA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 462 TABLE 803 SAUDI ARABIA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 462 TABLE 804 SAUDI ARABIA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 462 TABLE 805 SAUDI ARABIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 806 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 463 TABLE 807 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 463 TABLE 808 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 464 TABLE 809 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 464 TABLE 810 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 465 TABLE 811 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 465 TABLE 812 SAUDI ARABIA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 465 TABLE 813 UAE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 466 TABLE 814 UAE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 466 TABLE 815 UAE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 467 TABLE 816 UAE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 467 TABLE 817 UAE: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 468 TABLE 818 UAE: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 819 UAE: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 468 TABLE 820 UAE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 469 TABLE 821 UAE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 469 TABLE 822 UAE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 469 TABLE 823 UAE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 470 TABLE 824 UAE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 470 TABLE 825 UAE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 471 TABLE 826 UAE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 471 TABLE 827 UAE: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 471 TABLE 828 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 472 TABLE 829 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 472 TABLE 830 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 473 TABLE 831 REST OF GCC COUNTRIES: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 473 TABLE 832 REST OF GCC COUNTRIES: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 474 TABLE 833 REST OF GCC COUNTRIES: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 474 TABLE 834 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 474 TABLE 835 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 836 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 475 TABLE 837 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 475 TABLE 838 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 476 TABLE 839 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 476 TABLE 840 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 477 TABLE 841 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 477 TABLE 842 REST OF GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 477 TABLE 843 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 478 TABLE 844 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 478 TABLE 845 REST OF MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 478 TABLE 846 REST OF MIDDLE EAST: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 479 TABLE 847 REST OF MIDDLE EAST: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 479 TABLE 848 REST OF MIDDLE EAST: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 849 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 850 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 480 TABLE 851 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 481 TABLE 852 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 481 TABLE 853 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 481 TABLE 854 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 482 TABLE 855 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 482 TABLE 856 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 482 TABLE 857 REST OF MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 483 TABLE 858 MACROECONOMIC OUTLOOK FOR PHARMACEUTICAL FILTRATION MARKET IN AFRICA 484 TABLE 859 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 484 TABLE 860 AFRICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 485 TABLE 861 AFRICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 485 TABLE 862 AFRICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 485 TABLE 863 AFRICA: DEPTH FILTERS MARKET, BY TYPE OF MEDIA, 2023–2030 (USD MILLION) 486 TABLE 864 AFRICA: OTHER PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 486 TABLE 865 AFRICA: PHARMACEUTICAL FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 486 TABLE 866 AFRICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 867 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 487 TABLE 868 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023–2030 (USD MILLION) 487 TABLE 869 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 488 TABLE 870 AFRICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2023–2030 (USD MILLION) 488 TABLE 871 AFRICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023–2030 (USD MILLION) 489 TABLE 872 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023–2030 (USD MILLION) 489 TABLE 873 AFRICA: PHARMACEUTICAL FILTRATION MARKET, BY END USER, 2023–2030 (USD MILLION) 489 TABLE 874 STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET, 2022−2024 490 TABLE 875 PHARMACEUTICAL FILTRATION MARKET: DEGREE OF COMPETITION 493 TABLE 876 PHARMACEUTICAL FILTRATION MARKET: PRODUCT FOOTPRINT 498 TABLE 877 PHARMACEUTICAL FILTRATION MARKET: TECHNIQUE FOOTPRINT 499 TABLE 878 PHARMACEUTICAL FILTRATION MARKET: APPLICATION FOOTPRINT 500 TABLE 879 PHARMACEUTICAL FILTRATION MARKET: REGIONAL FOOTPRINT 501 TABLE 880 PHARMACEUTICAL FILTRATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES 504 TABLE 881 PHARMACEUTICAL FILTRATION: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 505 TABLE 882 PHARMACEUTICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 508 TABLE 883 PHARMACEUTICAL FILTRATION MARKET: DEALS, JANUARY 2022–NOVEMBER 2025 509 TABLE 884 PHARMACEUTICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 510 TABLE 885 MERCK KGAA: COMPANY OVERVIEW 511 TABLE 886 MERCK KGAA: PRODUCTS OFFERED 512 TABLE 887 MERCK KGAA: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 516 TABLE 888 DANAHER CORPORATION: COMPANY OVERVIEW 518 TABLE 889 DANAHER CORPORATION: PRODUCTS OFFERED 519 TABLE 890 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 525 TABLE 891 DANAHER CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 525 TABLE 892 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 525 TABLE 893 SARTORIUS AG: COMPANY OVERVIEW 527 TABLE 894 SARTORIUS AG: PRODUCTS OFFERED 528 TABLE 895 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 531 TABLE 896 SARTORIUS AG: DEALS, JANUARY 2022–NOVEMBER 2025 531 TABLE 897 SARTORIUS AG: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 531 TABLE 898 :SOLVENTUM: COMPANY OVERVIEW 533 TABLE 899 SOLVENTUM: PRODUCTS OFFERED 534 TABLE 900 SOLVENTUM: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 536 TABLE 901 SOLVENTUM: DEALS, JANUARY 2022–NOVEMBER 2025 537 TABLE 902 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–NOVEMBER 2025 537 TABLE 903 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW 539 TABLE 904 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED 540 TABLE 905 REPLIGEN CORPORATION: COMPANY OVERVIEW 543 TABLE 906 REPLIGEN CORPORATION: PRODUCTS OFFERED 544 TABLE 907 REPLIGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 546 TABLE 908 REPLIGEN CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 546 TABLE 909 EATON CORPORATION PLC: COMPANY OVERVIEW 547 TABLE 910 EATON CORPORATION PLC: PRODUCTS OFFERED 548 TABLE 911 EATON CORPORATION PLC: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 550 TABLE 912 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 551 TABLE 913 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED 552 TABLE 914 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2022–NOVEMBER 2025 555 TABLE 915 THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 555 TABLE 916 DONALDSON COMPANY, INC.: COMPANY OVERVIEW 557 TABLE 917 DONALDSON COMPANY, INC.: PRODUCTS OFFERED 558 TABLE 918 DONALDSON COMPANY, INC.: DEALS, JANUARY 2022–NOVEMBER 2025 559 TABLE 919 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 560 TABLE 920 PORVAIR PLC: COMPANY OVERVIEW 561 TABLE 921 PORVAIR PLC: PRODUCTS OFFERED 562 TABLE 922 PORVAIR PLC: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 564 TABLE 923 ALFA LAVAL CORPORATE AB: COMPANY OVERVIEW 565 TABLE 924 ALFA LAVAL CORPORATE AB: PRODUCTS OFFERED 566 TABLE 925 ALFA LAVAL CORPORATE AB: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 567 TABLE 926 CORNING INCORPORATED: COMPANY OVERVIEW 568 TABLE 927 CORNING INCORPORATED: PRODUCTS OFFERED 569 TABLE 928 MANN+HUMMEL: COMPANY OVERVIEW 572 TABLE 929 MANN+HUMMEL: PRODUCTS OFFERED 573 TABLE 930 MANN+HUMMEL: DEALS, JANUARY 2022–NOVEMBER 2025 574 TABLE 931 SAINT-GOBAIN: COMPANY OVERVIEW 575 TABLE 932 SAINT-GOBAIN: PRODUCTS OFFERED 576 TABLE 933 SAINT-GOBAIN: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 577 TABLE 934 SAINT-GOBAIN: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 577 TABLE 935 STERIS PLC: COMPANY OVERVIEW 578 TABLE 936 STERIS PLC: PRODUCTS OFFERED 579 TABLE 937 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 580 TABLE 938 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 581 TABLE 939 ASAHI KASEI CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–NOVEMBER 2025 581 TABLE 940 ASAHI KASEI CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025 582 TABLE 941 ASAHI KASEI CORPORATION: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 582 TABLE 942 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 583 TABLE 943 AMAZON FILTERS LTD.: COMPANY OVERVIEW 584 TABLE 944 GRAVER TECHNOLOGIES, LLC: COMPANY OVERVIEW 586 TABLE 945 MMS AG: COMPANY OVERVIEW 588 TABLE 946 ERTELALSOP: COMPANY OVERVIEW 589 TABLE 947 KASAG SWISS AG: COMPANY OVERVIEW 590 TABLE 948 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG: COMPANY OVERVIEW 591 TABLE 949 ANTYLIA SCIENTIFIC: COMPANY OVERVIEW 592 TABLE 950 FILTROX AG: COMPANY OVERVIEW 593 TABLE 951 MEMBRANE SOLUTIONS: COMPANY OVERVIEW 594 TABLE 952 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 603 FIGURE 1 PHARMACEUTICAL FILTRATION MARKET SEGMENTATION & REGIONAL SCOPE 55 FIGURE 2 PHARMACEUTICAL FILTRATION MARKET: YEARS CONSIDERED 57 FIGURE 3 MARKET SCENARIO 59 FIGURE 4 GLOBAL PHARMACEUTICAL FILTRATION MARKET, 2023–2030 60 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET, 2020–2025 60 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PHARMACEUTICAL FILTRATION MARKET 61 FIGURE 7 HIGH-GROWTH SEGMENTS IN PHARMACEUTICAL FILTRATION MARKET, 2025–2030 62 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL FILTRATION MARKET DURING FORECAST PERIOD 63 FIGURE 9 ADOPTION OF CONTINUOUS MANUFACTURING PROCESS TO DRIVE MARKET 64 FIGURE 10 STERILE FILTRATION SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA MARKET IN 2024 65 FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 66 FIGURE 12 PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67 FIGURE 13 PHARMACEUTICAL FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS 77 FIGURE 14 PHARMACEUTICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS 80 FIGURE 15 PHARMACEUTICAL FILTRATION MARKET: ECOSYSTEM ANALYSIS 82 FIGURE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024 85 FIGURE 17 PHARMACEUTICAL FILTRATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 91 FIGURE 18 INVESTOR DEALS AND FUNDING, 2023–2025 (USD MILLION) 91 FIGURE 19 TOP APPLICANTS/OWNERS (COMPANIES) FOR PHARMACEUTICAL FILTRATION PATENTS, 2014–2024 103 FIGURE 20 IMPACT OF AI/GEN AI ON PHARMACEUTICAL FILTRATION MARKET 105 FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 116 FIGURE 22 KEY BUYING CRITERIA, BY END USER 117 FIGURE 23 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 310 FIGURE 24 NIH FUNDING IN LAST 10 YEARS, 2015–2025 317 FIGURE 25 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT 378 FIGURE 26 PHARMACEUTICAL FILTRATION MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD BILLION) 492 FIGURE 27 PHARMACEUTICAL FILTRATION MARKET SHARE ANALYSIS, 2024 493 FIGURE 28 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 496 FIGURE 29 PHARMACEUTICAL FILTRATION MARKET: COMPANY FOOTPRINT, 2024 497 FIGURE 30 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 503 FIGURE 31 EV/EBITDA OF KEY VENDORS 506 FIGURE 32 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 506 FIGURE 33 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 507 FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2024) 512 FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 519 FIGURE 36 SARTORIUS AG: COMPANY SNAPSHOT (2024) 528 FIGURE 37 SOLVENTUM: COMPANY SNAPSHOT (2024) 534 FIGURE 38 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2024) 540 FIGURE 39 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2024) 544 FIGURE 40 EATON CORPORATION PLC: COMPANY SNAPSHOT (2024) 548 FIGURE 41 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2024) 552 FIGURE 42 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2024) 558 FIGURE 43 PORVAIR PLC: COMPANY SNAPSHOT (2024) 562 FIGURE 44 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2024) 566 FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 569 FIGURE 46 MANN+HUMMEL: COMPANY SNAPSHOT (2024) 573 FIGURE 47 SAINT-GOBAIN: COMPANY SNAPSHOT (2024) 576 FIGURE 48 STERIS PLC: COMPANY SNAPSHOT (2024) 579 FIGURE 49 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2024) 580 FIGURE 50 RESEARCH DESIGN 595 FIGURE 51 PHARMACEUTICAL FILTRATION MARKET: BREAKDOWN OF PRIMARIES 597 FIGURE 52 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 598 FIGURE 53 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024 599 FIGURE 54 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SARTORIUS AG (2024) 599 FIGURE 55 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 600 FIGURE 56 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 601 FIGURE 57 PHARMACEUTICAL FILTRATION MARKET: CAGR PROJECTIONS 602 FIGURE 58 DATA TRIANGULATION METHODOLOGY 604

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們